I have done both roles. Led field based and home office teams for more than 20 years and I’m getting ready to leave my current company for a hospital account position in rare disease and device. There are pros to being a manager. Many companies do not give stock to reps. The company I work for gives generous grants to managers and above. After vesting, I make about $100,000 more than the average rep on my team. So the money can be very good if you are in an orphan drug or rare disease situation. But I am tired of leading teams. I always treat my reps like peers and clients. It’s my job to make sure they have what they need and to help them get what the want. They are the people who put food on the table for my family. My reps are more important than my director or VP. Unfortunately, the new leadership I work for don’t see it that way. And that’s the way the industry appears to be headed. Directors and above are now heavily compensated with stock and options. All they care about are rankings, bonus, presidents club, and the stock price. This translates into constant meddling in our team business. Going around managers to intimidate and push their agenda. Myself and many other managers no longer lead. We measure useless metrics and parrot senior leadership direction. Time to move on.
If you love being a rep and you take good care of your customers, Stay put and develop in your role. You can shift into rare disease and make more than many managers in big pharma without the micro managed hell that is the DM role in the industry today.